Drug Prices
2023 Medical Loss Ratio Rebates
[ad_1] The Clinical Loss Ratio (MLR) provision of the Reasonably priced Care Act (ACA) limits the…
Drug Prices
Drug Prices
Drug Prices
Explaining Litigation Challenging the ACA’s Preventive Services Requirements: Braidwood Management Inc. v. Becerra
[ad_1] Notice: This content material has been up to date to include new trends within the…
Drug Prices
Preventive Services Covered by Private Health Plans under the Affordable Care Act
[ad_1] Notice: This content material has been up to date to include new tendencies within the…
Drug Prices
Standardized Plans in the Health Care Marketplace: Changing Requirements
[ad_1] Background For the 2023 protection yr, HealthCare.gov followed a demand on collaborating medical health insurance…
Drug Prices
Presentation: The End of the Public Health Emergency Declaration for COVID-19
[ad_1] This slideshow calls for JavaScript. Jen Kates, Senior Vice President and Director of KFF’s World…
Drug Prices
How Many People Might Lose Medicaid When States Unwind Continuous Enrollment?
[ad_1] Beginning April 1, 2023 some states resumed disenrolling folks from Medicaid after a three-year length…
Drug Prices
Section 1115 Waiver Watch: Continuous Eligibility Waivers and Implications for Unwinding
[ad_1] Beginning April 1, 2023, states can resume Medicaid disenrollments for the primary time in 3…
Drug Prices
Q&A: Implications of the Ruling on the ACA’s Preventive Services Requirement
[ad_1] Notice: This put up was once up to date on April 4, 2023, to incorporate…
Drug Prices
How Many Uninsured Are in the Coverage Gap and How Many Could be Eligible if All States Adopted the Medicaid Expansion?
[ad_1] The tip of the Medicaid steady enrollment provision in March 2023 and the resumption of…
Drug Prices
Increasingly Privatized Public Health Insurance Programs in the US
[ad_1] KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Telephone 650-854-9400 Washington…
